The Latest Cardiac and Vascular News
Bagsværd, Denmark, 24 September 2020 – Novo Nordisk today announced the results of the CAPTURE study, a global non-interventional study to uncover the prevalence of cardiovascular disease and risk and its management in people living with type 2 diabetes. The study, the first of its kind and involving nearly 10,000 participants […]
OSAKA, Japan–(BUSINESS WIRE)–Gunze Limited (Headquarters: Osaka, Japan, President: Atsushi Hirochi) [TOKYO:3002] is pleased to announce that Gunze’s biodegradable scaffolds are being provided to the Abigail Wexner Research Institute at Nationwide Children’s Hospital (Location: Columbus, OH, USA) to conduct its first human tissue engineered vascular grafts (hereinafter TEVG), clinical trial. 1. […]
HONG KONG, Sept. 23, 2020 /PRNewswire/ — OrbusNeich Medical Co. Ltd. has announced that the National Medical Products Administration (NMPA) has granted market approval for the COMBO BIO-ENGINEERED SIROLIMUS ELUTING STENT in China. It is the first dual therapy stent to both accelerate endothelial coverage and control neointimal proliferation through the combination of the […]
DUBLIN, Sept. 23, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™ Insertable Cardiac Monitor (ICM) in identifying patients at high-risk of worsening heart failure. The trial will determine if early […]
DUBLIN, Sept. 22, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the TYRX™ Absorbable Antibacterial Driveline Wrap, which is intended to securely hold a percutaneous driveline in patients receiving a ventricular assist device (VAD). […]
Funds Support Further Development of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure and Pulmonary Hypertension CAESAREA, Israel and AGOURA HILLS, Calif., Sept. 22, 2020 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced […]
SALINAS, Calif., Sept. 23, 2020 /PRNewswire/ — During unprecedented challenges in healthcare, Salinas Valley Memorial Healthcare System (SVMHS) is providing medical leadership during COVID-19 and earning awards for exceptional patient care in the area of heart treatment. SVMHS is one of only 60 hospitals nationwide to receive the American College of Cardiology’s NCDR […]
Company Advances Second Cardiac Myosin Inhibitor SOUTH SAN FRANCISCO, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 placebo-controlled, single ascending dose clinical study of CK-3772271 (CK-271). CK-271 is a second cardiac myosin inhibitor, discovered […]
TEL AVIV, Israel, Sept. 23, 2020 (GLOBE NEWSWIRE) — OnSight Medical, a leading AI ultrasound company specializing in cardiology, today announced Rick Heinick will be joining its Board of Directors. Mr. Heinick is a recognized healthcare entrepreneur, who founded the ophthalmic pharmaceutical company TearClear, serving as its Executive Chairman for […]
Next-generation technology provides easy, effective clot removal from peripheral arterial vasculature EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce™ Thrombus Retrieval System. […]
